Table 1.
Variable | Participant Role | Pre- CBLC |
Post- CBLC |
Fe | p | ηp2 |
---|---|---|---|---|---|---|
M | M | |||||
(SD) | (SD) | |||||
Collaboration | Totala | 22.36 (5.95) |
24.94 (6.27) |
60.04 | <.001 | .17 |
Clinicianb | 21.88 (6.38) |
23.73 (6.08) |
||||
Brokerc | 21.62 (5.72) |
24.97 (6.14) |
||||
Senior Leaderd | 24.03 (4.82) |
27.55 (6.05) |
||||
Barriers | Totala | 35.14 (9.14) |
29.49 (8.26) |
98.48 | <.001 | .25 |
Clinicianb | 33.55 (8.92) |
28.09 (7.37) |
||||
Brokerc | 38.32 (8.83) |
33.21 (9.21) |
||||
Senior Leaderd | 35.90 (9.17) |
29.12 (8.28) |
||||
Utilization | Totala | 31.97 (21.02) |
45.62 (22.88) |
63.04 | <.001 | .17 |
Clinicianb | 30.75 (21.65) |
45.86 (23.52) |
||||
Brokerc | 32.39 (17.79) |
40.77 (22.92) |
||||
Senior Leaderd | 34.27 (22.19) |
49.26 (20.90) |
Note.
N = 306.
n = 165.
n = 65.
n = 76.
df = 1, 303.
ηp2 = partial eta squared.